SI-614

DRUG2 trials

Sponsors

Seikagaku Corporation

Conditions

Dry Eye DiseaseDry Eye Syndromes

Phase 2

A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.

CompletedNCT02205840

Seikagaku CorporationDry Eye Syndromes

Start: 2014-07-31Updated: 2023-07-12

Phase 3

A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye

CompletedNCT05411367

Seikagaku CorporationDry Eye Disease

Start: 2022-07-28End: 2023-04-27Updated: 2026-01-16